Novel approaches to propagate molluscum contagiosum virus in cell culture
在细胞培养中繁殖传染性软疣病毒的新方法
基本信息
- 批准号:9089855
- 负责人:
- 金额:$ 24.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdultAntiviral ResponseAttenuatedBenignBiologyCell CommunicationCell Culture SystemCell Culture TechniquesCell LineCell modelCellsChildCollectionCommunitiesComplementCultured CellsDevelopmentDistressElementsEnvironmentEpidermisExtramural ActivitiesFamilyFundingFutureGenesGoalsGrowthHIVHealthHealth Care CostsHumanImmuneImmunocompromised HostIn VitroIndividualInfectionInfectious Skin DiseasesKnowledgeLesionLife Cycle StagesLinkMedicalModelingMolluscum ContagiosumMolluscum contagiosum virusOffice VisitsOrthopoxvirusParentsPathway interactionsPatientsPhysiologyPopulationPoxviridaePropertyProteinsResearchResearch ProposalsRoleScientistSignal PathwaySignal TransductionSkinSkin TissueStagingSystemTechnical ExpertiseTestingTherapeuticTissuesUnited States National Institutes of HealthViralViral GenomeVirusVirus DiseasesVirus ReplicationWorkbaseburden of illnesscellular targetingcostemotional distressgene productimmortalized cellimmunosuppressedin vivoinsightkeratinocytenovel strategiespathogenskin barrierskin disorderskin disorder diagnosisskin lesiontherapeutic developmenttransmission processtwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): Molluscum contagiosum (MC) is a common skin infection caused by molluscum contagiosum virus (MoCV), a dermatotropic poxvirus. MC presents as single to multiple skin lesions that last from months to years. Transmission is by direct skin-to-skin contact or by indirect contact with fomites. MC lesions are solely restricted t human skin and occur in children, adults, and immunosuppressed individuals. While the lesions are benign, they are often unsightly and thus are psychologically distressful to patients and parents. MC occurs in 2-10% of the worldwide population. In the USA, it constitutes about 1% of all diagnosed skin disorders and occurs in almost 5% of children. In immune-compromised individuals, MC is severe and protracted. Between 5- 18% of HIV patients have MC. Despite the huge burden of disease and the associated significant healthcare costs, there are no extramural NIH-funded projects that specifically study this virus. The major impediment in researching MoCV and finding potential therapeutic cures for MC has been the inability of MoCV to propagate in any type of cultured cells. The objective of this R21 project is to use various novel strategies to identify a system that would allow replication of MoCV in cell culture. We hypothesize that the inability to propagate MoCV in cells in culture is linked to the inability of MoCV to downregulate a cell's innate anti-viral responses. It also reflects unique properties of the human epidermis in vivo that are not reproduced during culture in vitro. We hypothesize that this block in productive infection can be overcome by manipulation of cells in culture to create an intracellular environment that would allow the full MoCV life cycle to be carried out. By establishing models for the growth of MoCV in cell culture and identifying the factors that regulate its replication in keratinocytes, we will gain insights into unique features of skin cells
that allow dermatotropic viruses like MoCV to grow and spread in the skin, which will, in the future, serve as a basis for further study and potential development of therapeutics. To test these concepts we will: * Determine at what stage MoCV infection is blocked in both primary human keratinocytes and immortalized cells * Manipulate the host cell microenvironment with poxviral proteins not expressed by MoCV * Manipulate the host cell innate-antiviral responses by targeting cellular proteins By combining Penn's on-campus research expertise in poxvirology and human epidermal biology, we believe that we are poised to make a major advance in poxvirology and discover a way to allow the propagation and spread of MoCV in cell culture systems. Support through this R21 application will allow us begin the steps to reach this important and significant goal.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stuart N. Isaacs其他文献
Antipyretic orders in a university hospital.
大学医院的退烧药单。
- DOI:
10.1016/0002-9343(90)90124-v - 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
Stuart N. Isaacs;Peter Axelrod;Bennett Lorber - 通讯作者:
Bennett Lorber
Poxvirus vaccines: the evolution of an 18th-century vaccine to the 21st century
- DOI:
10.1016/j.tips.2024.10.015 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Yuhong Xiao;Stuart N. Isaacs - 通讯作者:
Stuart N. Isaacs
Peripheral blood cytokine profiles predict the severity of SARS-CoV-2 infection: an EPIC3 study analysis
- DOI:
10.1186/s12879-025-10914-6 - 发表时间:
2025-05-08 - 期刊:
- 影响因子:3.000
- 作者:
Xumin Li;Vivek Pakanati;Cindy Liu;Tracy Wang;Daniel Morelli;Anna Korpak;Aaron Baraff;Stuart N. Isaacs;Amy Vittor;Kyong-Mi Chang;Elizabeth Le;Nicholas L. Smith;Jennifer S. Lee;Jennifer M. Ross;Javeed A. Shah - 通讯作者:
Javeed A. Shah
Stuart N. Isaacs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stuart N. Isaacs', 18)}}的其他基金
XXIII International Poxvirus, Asfarvirus, and Iridovirus Conference
第二十三届国际痘病毒、阿斯法病毒和虹彩病毒会议
- 批准号:
9993673 - 财政年份:2021
- 资助金额:
$ 24.62万 - 项目类别:
Enhancement and Expansion: Penn Neurophysiology and Behavior Testing Facility
增强和扩展:宾夕法尼亚大学神经生理学和行为测试设施
- 批准号:
9120117 - 财政年份:2016
- 资助金额:
$ 24.62万 - 项目类别:
Smallpox vaccine and vaccinia complement control protein
天花疫苗和牛痘补体控制蛋白
- 批准号:
7901695 - 财政年份:2009
- 资助金额:
$ 24.62万 - 项目类别:
Optimizing the formulation of a protein based smallpox vaccine
优化基于蛋白质的天花疫苗的配方
- 批准号:
7616506 - 财政年份:2008
- 资助金额:
$ 24.62万 - 项目类别:
Optimizing the formulation of a protein based smallpox vaccine
优化基于蛋白质的天花疫苗的配方
- 批准号:
7802243 - 财政年份:2008
- 资助金额:
$ 24.62万 - 项目类别:
Optimizing the formulation of a protein based smallpox vaccine
优化基于蛋白质的天花疫苗的配方
- 批准号:
8056790 - 财政年份:2008
- 资助金额:
$ 24.62万 - 项目类别:
Optimizing the formulation of a protein based smallpox vaccine
优化基于蛋白质的天花疫苗的配方
- 批准号:
8259455 - 财政年份:2008
- 资助金额:
$ 24.62万 - 项目类别:
Optimizing the formulation of a protein based smallpox vaccine
优化基于蛋白质的天花疫苗的配方
- 批准号:
7454535 - 财政年份:2008
- 资助金额:
$ 24.62万 - 项目类别:
New Opportunities - Mechanisms of Early Vaccinia Viral Morphogensis
新机遇——早期牛痘病毒形态发生机制
- 批准号:
7680587 - 财政年份:2008
- 资助金额:
$ 24.62万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 24.62万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 24.62万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 24.62万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 24.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 24.62万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 24.62万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 24.62万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 24.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 24.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 24.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)